Sophia Genetics Sa (SOPH) has released an update.
Sophia Genetics SA has reported a narrower loss in the first quarter of 2024 compared to the same period in 2023, with a loss per share reducing from $0.31 to $0.21. The company’s revenue has increased from $13,966 thousand to $15,779 thousand, indicating a positive trajectory in financial performance. These financial results reflect the company’s ongoing efforts to manage costs and optimize revenue streams.
For further insights into SOPH stock, check out TipRanks’ Stock Analysis page.
